Costello Asset Management’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-385
Closed -$15.1K – 183
2023
Q3
$15.1K Buy
385
+6
+2% +$239 0.01% 128
2023
Q2
$15.4K Buy
379
+6
+2% +$247 0.01% 129
2023
Q1
$15.6K Buy
373
+5
+1% +$210 0.02% 131
2022
Q4
$16K Buy
368
+6
+2% +$255 0.01% 134
2022
Q3
$14K Buy
362
+5
+1% +$213 0.01% 137
2022
Q2
$15K Buy
357
+5
+1% +$217 0.01% 146
2022
Q1
$16K Buy
+352
New +$15.6K 0.01% 157

Other funds holding BME

Costello Asset Management's BME Position: Q4 2023 in Review

Costello Asset Management sold out of BlackRock Health Sciences Trust (BME) in Q4 2023, closing a stake of 385 shares — an estimated $15.1K sold.

Costello Asset Management first reported a position in BME in Q1 2022 and held it in 7 quarters. The position peaked at $16K in Q4 2022. 73 funds tracked by Wall St. Rank hold BME as of Q4 2023.

  • Costello Asset Management reported no remaining BlackRock Health Sciences Trust position as of Q4 2023 after selling out during the quarter.
  • Costello Asset Management sold 385 BlackRock Health Sciences Trust shares in Q4 2023, an estimated $15.1K.
  • Costello Asset Management first reported a position in BlackRock Health Sciences Trust in Q1 2022 and held it in 7 quarters.
  • Costello Asset Management's BlackRock Health Sciences Trust position peaked at $16K in Q4 2022.
  • 73 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q4 2023.

Based on Costello Asset Management's 13F filing for Q4 2023, filed 29 Jan 2024.